Healthcare -
Biotechnology - NASDAQ - US
$ 3.91
0.256 %
$ 349 M
Market Cap
-8.89
P/E
TRVI - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss TRVI - Trevi Therapeutics, Inc.
-29 K
LAST VALUE
0.00%
2 YEAR CAGR
8.81%
5 YEAR CAGR
0.00%
10 YEAR CAGR